[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345015-105":59,"doc-detail-345015-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","cell-free-dna-as-biomarker-in-oral-squamous-cell-carcinoma-dynamics-mutational-landscape-and-clinical-implications","Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma - Dynamics, Mutational Landscape and Clinical Implications","","Oral squamous cell carcinoma (OSCC) is a common head and neck cancer with persistently poor outcomes, especially in advanced disease. Liquid biopsy using cell-free DNA (cfDNA) from plasma and urine offers a non-invasive strategy for detection and monitoring. This study quantified cfDNA dynamics in 32 OSCC patients, with a subset undergoing targeted next-generation sequencing (NGS). cfDNA rose in patients versus controls, increased transiently after treatment start, and returned toward baseline, but did not correlate with stage, recurrence, or progression-free survival. Targeted NGS uncovered heterogeneous mutations, including 76 variants across tissue and initial cfDNA and 30.3% shared between sources, with urine adding additional mutations absent from plasma or tissue. Results support dynamic response monitoring and tumor heterogeneity capture, while emphasizing the limited prognostic value of cfDNA quantification alone and the need for multidimensional genomic and clinical assessment.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cell-free-dna-as-biomarker-in-oral-squamous-cell-carcinoma-dynamics-mutational-landscape-and-clinical-implications/345015/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cell-free-dna-as-biomarker-in-oral-squamous-cell-carcinoma-dynamics-mutational-landscape-and-clinical-implications/345015.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"How did cfDNA levels change after treatment initiation in OSCC patients?","Question",{"text":112,"@type":113},"cfDNA concentrations increased transiently after treatment initiation, likely reflecting tumor cell death, and then gradually returned toward baseline.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Did cfDNA concentrations correlate with tumor stage, recurrence, or progression-free survival?",{"text":117,"@type":113},"No. cfDNA concentrations were not significantly associated with tumor stage, recurrence, or progression-free survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What did targeted NGS reveal about the mutational landscape in tumor tissue and cfDNA?",{"text":121,"@type":113},"Targeted NGS identified 76 variants across tumor tissue and initial cfDNA, with 30.3% shared between both sources, and detected recurrent hotspot mutations in genes such as TP53, PIK3CA, KRAS, APC, and FBXW7.",{"name":123,"@type":110,"acceptedAnswer":124},"Why is urine cfDNA considered complementary to plasma or tissue cfDNA?",{"text":125,"@type":113},"Urine cfDNA captured several mutations that were absent from plasma or tissue, supporting its complementary value for molecular monitoring.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},345015,1790111766,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Article  \nCell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma: Dynamics, Mutational Landscape and Clinical Implications  \nPedro Veiga 1, Leonor Barroso 2, Luís Miguel Pires 1, Carolina Mano 1, Francisco Caramelo 3,4,5,6, Isabel Marques Carreira 1,4,5,6, Ilda Patrícia Ribeiro 1,4,5,6, * and Joana Barbosa de Melo 1,4,5,6  \nAcademic Editor: Alexander  \nE. Kalyuzhny  \nReceived: 13 February 2026  \nRevised: 10 March 2026  \nAccepted: 17 March 2026  \nPublished: 23 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine,  \nUniversity of Coimbra, 3004-531 Coimbra, Portugal; [pveiga@fmed.uc.pt](pveiga@fmed.uc.pt) (P.V.); [lmlmpires@gmail.com](lmlmpires@gmail.com) (L.M.P.);  \n[carolinasequeiramano@gmail.com](carolinasequeiramano@gmail.com) (C.M.); [icarreira@fmed.uc.pt](icarreira@fmed.uc.pt) (I.M.C.); [mmelo@fmed.uc.pt](mmelo@fmed.uc.pt) (J.B.d.M.)  \n2 Maxillofacial Surgery Department, Unidade Local de Saúde de Coimbra, 3004-561 Coimbra, Portugal; [leonorbarroso@gmail.com](leonorbarroso@gmail.com)  \n3 Laboratory of Biostatistics and Medical Informatics, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal; [fcaramelo@fmed.uc.pt](fcaramelo@fmed.uc.pt)  \n4 Center of Investigation on Environment Genetics and Oncobiology (CIMAGO), Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, 3004-531 Coimbra, Portugal  \n5 Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-531 Coimbra, Portugal  \n6 Clinical Academic Center of Coimbra (CACC), Hospitais da Universidade de Coimbra, 3004-561 Coimbra, Portugal  \n* Correspondence: [iribeiro@uc.pt](iribeiro@uc.pt); Tel.: +351-239-480-027  \nAbstract  \nOral squamous cell carcinoma (OSCC) is a prevalent form of head and neck cancer that typically develops on the lip or within the oral cavity. Although there have been advances in early detection and treatment, the prognosis for patients, particularly those with advancedstage disease, remains poor. Liquid biopsy, particularly through the analysis of cell-free DNA (cfDNA) in plasma and urine, has emerged as a promising tool for non-invasive cancer detection and monitoring. This study assessed cfDNA concentration dynamics in plasma and urine samples from 32 OSCC patients, with 5 undergoing genomic characterization by targeted next-generation sequencing (NGS) . CfDNA levels were higher in patients compared to healthy controls and showed transient increases following treatment initiation, likely reflecting tumor cell death, followed by a gradual return to baseline. However, cfDNA concentrations were not significantly associated with tumor stage, recurrence, or progression-free survival. Targeted NGS analysis revealed a heterogeneous mutational landscape, identifying 76 variants across tumor tissue and initial cfDNA, with 30.3% shared between both sources. Recurrent hotspot mutations were detected in several important genes, including TP53, PIK3CA, KRAS, APC, and FBXW7 . Urine cfDNA also captured several mutations absent from plasma or tissue, supporting its complementary value. These findings demonstrate that cfDNA analysis can dynamically reflect treatment response and capture tumor heterogeneity in OSCC. While informative, cfDNA quantification alone offers limited prognostic reliability, reinforcing the need for a multidimensional approach that includes genomic and clinical evaluation. Overall, this study supports the potential of liquid biopsy as a real-time, non-invasive tool for molecular monitoring and personalized management of OSCC patients.  \nKeywords: oral squamous cell carcinoma; liquid biopsy; next-generation sequenci","cbCaitX2n3QBSdgn","https://ap.wps.com/l/cbCaitX2n3QBSdgn","pdf",1555611,17,"English","# Abstract\n# Introduction\n# Materials and Methods\n# Results\n# Discussion\n# Conclusions","[{\"question\":\"How did cfDNA levels change after treatment initiation in OSCC patients?\",\"answer\":\"cfDNA concentrations increased transiently after treatment initiation, likely reflecting tumor cell death, and then gradually returned toward baseline.\"},{\"question\":\"Did cfDNA concentrations correlate with tumor stage, recurrence, or progression-free survival?\",\"answer\":\"No. cfDNA concentrations were not significantly associated with tumor stage, recurrence, or progression-free survival.\"},{\"question\":\"What did targeted NGS reveal about the mutational landscape in tumor tissue and cfDNA?\",\"answer\":\"Targeted NGS identified 76 variants across tumor tissue and initial cfDNA, with 30.3% shared between both sources, and detected recurrent hotspot mutations in genes such as TP53, PIK3CA, KRAS, APC, and FBXW7.\"},{\"question\":\"Why is urine cfDNA considered complementary to plasma or tissue cfDNA?\",\"answer\":\"Urine cfDNA captured several mutations that were absent from plasma or tissue, supporting its complementary value for molecular monitoring.\"}]","Cell-Free DNA as Biomarker in Oral Squamous Cell Carcinoma - Dynamics, Mutational Landscape and Clinical Implications | PDF",1790056215,43,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/081be283b9f4913c84721e026f00f8cd.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d934a12c37890e015418ba0431d163c.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e524655403ecb03ead6c818eeb4fc5d7.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ccc20ef9bcc64b37927b2b7df0cca9a7.webp",980,1385]